Plasma proteome as organ-aging readout
ОсновнаяTeal Rise's core theory is that age-related molecular changes in specific organs are reflected in circulating plasma proteins, so proteomic measurements can be used to infer organ-specific biological age. If this mechanism is valid, organ-specific protein signatures should track health status, differ across organs within the same person, and predict organ-linked disease risk better than chronological age alone.
Попперовская оценка
The premise is biologically credible: organs release or influence circulating proteins, and aging can change tissue function, inflammation, secretion, and damage signals. The theory also makes a stronger claim, that plasma retains enough organ-specific signal to separate biological aging across organs inside one person. That part is plausible, but still exposed to confounding from systemic inflammation, kidney clearance, medication, and general frailty.
Подтверждающие доказательства: The cited 2023 publication reports organ aging signatures in the plasma proteome that track health and disease.; The theory predicts organ-specific signatures, disease tracking, and within-person organ differences, which fits a mechanistic plasma readout model.
Контрдоказательства: Only one directly relevant publication is supplied.; Several supplied publications concern ducks, seed dispersal, blood grouping, or wetland birds and do not support the organ-aging claim.
The theory explains why a blood test could carry organ-linked aging information and why different organs in the same person might show different apparent ages. The weak point is specificity. A plasma proteome signal could reflect broad illness burden, inflammation, renal filtration, or cardiovascular risk rather than true organ-level aging. The evidence says the signatures track health and disease, but that alone does not prove the proteins report aging mechanisms inside each organ.
Подтверждающие доказательства: The cited publication reports that organ aging signatures in plasma track health and disease.; The model predicts disease risk beyond chronological age, which is the right comparison for an aging readout.
Контрдоказательства: The supplied context does not show whether the signatures outperform simpler clinical variables or general proteomic aging scores.; No direct evidence is supplied for causal organ aging rather than correlated disease state.
This theory is testable. It can fail if organ-specific protein signatures do not differ across organs within the same person, do not track measured organ health, or do not predict organ-linked disease better than chronological age. It can also fail in external cohorts if signatures collapse after adjustment for comorbidities, medications, inflammation, or kidney function. That is a clean Popperian setup: the theory risks being wrong in measurable ways.
Подтверждающие доказательства: The theory gives concrete predictions about health status, within-person organ differences, and disease-risk prediction beyond chronological age.; The predictions can be tested with longitudinal cohorts, organ-specific clinical endpoints, and held-out validation sets.
Контрдоказательства: The supplied context does not define effect-size thresholds, endpoint lists, or the minimum performance gain over chronological age.; Without pre-specified validation rules, weak correlations could be overread as support.
Дерево рассуждений
Публичные одобрения
Okumus is publicly linked to Teal's organ-age thesis. The evidence says he co-founded Teal Omics and appears in podcast and video listings about "the measurability of the age of individual organs" and "determining the biological age of our organs." That is a clear public mention of the theory, but the dossier does not provide a direct quote from him explicitly defending the plasma-proteome mechanism itself.
Evidence publication IDs: 61ee73ea-bd23-4667-bf8d-39d4e22ae4a3, 0e1cd4cb-a6de-4449-afb0-f5cb876c63f7, 51f25d42-0993-436e-8f82-14ed2b8ec5e2, 792dc384-beb6-421d-970f-abeec5a3136e
Wyss-Coray is publicly tied to the core claim, not just adjacent aging work. One public description says he measures organ age through blood, including heart and brain aging. The Olink podcast record goes further: it says Teal Rise was founded with Tony and describes the company as building models from large plasma proteomics datasets to predict disease, while the Teal Rise site says it assesses how individual organs are aging relative to peers. That matches the theory that plasma proteins can read out organ-specific aging.
Evidence publication IDs: 2f9ae6d2-7594-4873-b053-7b72e072c76f, 2b4ed2f9-0c53-4a66-bfda-283785b3e174
The evidence does not show Wenyu Zhou making any public statement about Teal Rise's theory. The only record is a company page that lists Teal Rise's proteomics-based aging work and mentions Zhou in a separate recognition item, which is not an endorsement, explanation, or criticism of the theory.